Keith Lamont Cummings, CFO of Pliant Therapeutics, Inc. ($PLRX), made one open market sale of PLRX shares in the last year, totaling $30,723. His most recent PLRX insider sale occurred on January 20, 2026. This ranks 10,798th among 11,678 insiders by sales value, well below the average of $8.6 million over 6.4 transactions. No open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 22, 2026 | PLIANT THERAPEUTICS, INC. | $PLRX | Cummings Keith Lamont | Chief Financial Officer | A | Stock Option (Right to Buy) | 400000 | $0.00 | 400,000.0000 | 61,449,385 | 9999.99% | 0.65% |
| Jan. 20, 2026 | PLIANT THERAPEUTICS, INC. | $PLRX | Cummings Keith Lamont | Chief Financial Officer | S | Common Stock | 24002 | $1.28 | 297,214.0000 | 61,449,385 | 7.47% | 0.04% |
| Jan. 23, 2025 | PLIANT THERAPEUTICS, INC. | $PLRX | Cummings Keith Lamont | Chief Financial Officer | A | Common Stock | 56650 | $0.00 | 319,258.0000 | 0 | 21.57% | 0.00% |
| Jan. 23, 2025 | PLIANT THERAPEUTICS, INC. | $PLRX | Cummings Keith Lamont | Chief Financial Officer | A | Stock Option (Right to Buy) | 113300 | $0.00 | 113,300.0000 | 0 | 9999.99% | 0.00% |
| Jan. 17, 2025 | PLIANT THERAPEUTICS, INC. | $PLRX | Cummings Keith Lamont | Chief Financial Officer | S | Common Stock | 20148 | $11.20 | 262,608.0000 | 0 | 7.13% | 0.00% |
| July 10, 2024 | PLIANT THERAPEUTICS, INC. | $PLRX | Cummings Keith Lamont | Chief Financial Officer | S | Common Stock | 10911 | $11.56 | 282,115.0000 | 0 | 3.72% | 0.00% |
| July 9, 2024 | PLIANT THERAPEUTICS, INC. | $PLRX | Cummings Keith Lamont | Chief Financial Officer | A | Common Stock | 21313 | $0.00 | 293,026.0000 | 0 | 7.84% | 0.00% |
| May 2, 2024 | PLIANT THERAPEUTICS, INC. | $PLRX | Cummings Keith Lamont | Chief Financial Officer | M | Stock Option (Right to Buy) | 21000 | $0.00 | 76,047.0000 | 0 | 21.64% | 0.00% |
| May 2, 2024 | PLIANT THERAPEUTICS, INC. | $PLRX | Cummings Keith Lamont | Chief Financial Officer | M | Common Stock | 21000 | $2.08 | 271,713.0000 | 0 | 8.38% | 0.00% |
| Jan. 23, 2024 | PLIANT THERAPEUTICS, INC. | $PLRX | Cummings Keith Lamont | Chief Financial Officer | A | Common Stock | 55250 | $0.00 | 249,855.0000 | 0 | 28.39% | 0.00% |
| Jan. 23, 2024 | PLIANT THERAPEUTICS, INC. | $PLRX | Cummings Keith Lamont | Chief Financial Officer | A | Stock Option (Right to Buy) | 110500 | $0.00 | 110,500.0000 | 0 | 9999.99% | 0.00% |
| Jan. 17, 2024 | PLIANT THERAPEUTICS, INC. | $PLRX | Cummings Keith Lamont | Chief Financial Officer | S | Common Stock | 9781 | $17.23 | 194,605.0000 | 0 | 4.79% | 0.00% |